Reports are emerging from the san antonio breast cancer symposium, referred to as sabcs, for the year 2025. The event has featured various presentations, including results from clinical trials such as the lidera and ascent-07 trials, as well as the gepardouze study. The number of notable posts or takeaways from the event is unclear, with different outlets citing different numbers.